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Background:  Evidence suggests that IL-6 plays a critical role in atherogenesis, but it is still unclear whether the genetic variability of IL-6 gene 
is involved into mechanisms of atherosclerosis. Therefore, we examined the impact of genetic polymorphism G174C on IL-6 gene, on endothelial 
function, acute phase response and coronary atherosclerosis burden.
Methods:  The study population consisted of 123 patients with newly diagnosed, angiographically documented coronary atherosclerosis. G174C 
polymorphism was estimated by PCR, while serum levels of C-reactive protein (CRP) were measured by immunonephelometry. Endothelial function 
was measured by estimating flow-mediated dilation of the brachial artery (FMD), by ultrasound.
Results:  The genotype distribution was GG: 57 (46.3%), GC: 45 (36.6%) and C: 21(17.1%). Importantly, homozygosity for the C allele was 
associated with significantly lower atherosclerosis onset age (59.1±2.3 years) compared to GC (64.7±1.24 years) and GG(65.1±1.23) (p(for 
trend)<0.05). No significant association was found between G174C polymorphism and the angiographic extend of coronary artery disease (1 vessel 
disease (VD):GG51.4%, GC:32.4% and CC:16.2%, 2VD: GG:53.1%, GC:28.1% and CC:18.8% or 3VD: GG:41.9%, GC:38.7% and CC: 19.4%, (p=NS 
between genotypes). Moreover, this polymorphism was not associated with differences in CRP (CC: 2.51±1.66mg/dl, GC:4.16±2.22mg/dl and GG: 
2.16±0.56mg/dl, p=NS) and changes in FMD, CC (3.67±1.34%) and GC (3.97±1.04%) compared to GG(4.61±0.73%)(p=NS).
Conclusion: Genetic polymosphism G174C on IL-6 gene is associated with earlier appearance of coronary atherosclerosis. This effect is 
independent of endothelial function and acute phase response. These findings suggest that G174C polymorphism may be implicated in 
atherogenesis, by accelerating the progression of coronary artery disease.
